Skip to content
  • Tuesday, 27 October 2026
  • 2:02 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • AstraZeneca and Daiichi Sankyo Join Forces with Summit Therapeutics in Strategic Clinical Partnership to Evaluate Novel Oncology Combinations
Pharmaceutical R&D

AstraZeneca and Daiichi Sankyo Join Forces with Summit Therapeutics in Strategic Clinical Partnership to Evaluate Novel Oncology Combinations

Teuku Ryan Oct 2, 2026 0

The oncology landscape is undergoing a significant strategic consolidation as major pharmaceutical players align their pipelines to maximize the therapeutic…

Read More
Pharmaceutical R&D

AstraZeneca Deepens Oncology Footprint with $2bn Equity Investment in Summit Therapeutics to Advance Next-Generation Cancer Combinations

Teuku Ryan Sep 29, 2026 0

AstraZeneca has announced a landmark $2bn equity investment in Summit Therapeutics, marking a major strategic alignment between the pharmaceutical giants…

Read More
Laboratory Automation & Robotics

Immunai’s Digital ‘Plumbing’ Keeps AstraZeneca Coming Back

Lana Keisha Jul 3, 2026 0

Immunai, a pioneering startup dedicated to constructing a comprehensive foundation model of the human immune system, has significantly deepened its…

Read More
Laboratory Automation & Robotics

Immunai’s digital ‘plumbing’ keeps AstraZeneca coming back

Lana Keisha Jun 26, 2026 0

Immunai, a pioneering startup dedicated to constructing a foundational model of the human immune system, has announced a significant expansion…

Read More
Laboratory Automation & Robotics

Immunai’s digital ‘plumbing’ keeps AstraZeneca coming back

Lana Keisha Jun 17, 2026 0

Immunai, a pioneering startup dedicated to constructing a foundational model of the human immune system, has significantly expanded its oncology…

Read More
Pharmaceutical R&D

AbbVie Secures FDA Approval for Ultra-Rare Blood Cancer Therapy, While AstraZeneca Faces Delay for Breast Cancer Drug

Teuku Ryan May 31, 2026 0

The U.S. Food and Drug Administration (FDA) has recently issued a significant approval for AbbVie’s antibody-drug conjugate (ADC) targeting blastic…

Read More
Laboratory Automation & Robotics

Immunai’s Digital "Plumbing" Secures Third Expansion with AstraZeneca, Deepening AI Integration Across Clinical Pipeline

Lana Keisha May 29, 2026 0

Immunai, a pioneering startup dedicated to constructing a foundational model of the human immune system, has announced its third significant…

Read More
Laboratory Automation & Robotics

Immunai’s Digital ‘Plumbing’ Keeps AstraZeneca Coming Back for Broader, Deeper Collaborations

Lana Keisha May 22, 2026 0

Immunai, a pioneering startup dedicated to constructing a foundational model of the human immune system, has significantly expanded its strategic…

Read More
Pharmaceutical R&D

AstraZeneca’s Targeted Treatment Offers New Hope for Stomach Cancer Patients in the UK

Teuku Ryan May 15, 2026 0

AstraZeneca’s groundbreaking targeted therapy, Imfinzi (durvalumab), has secured a pivotal recommendation from the National Institute for Health and Care Excellence…

Read More
Pharmaceutical R&D

UAE Becomes First Nation to Approve AstraZeneca’s Baxfendy for Uncontrolled Hypertension

Teuku Ryan May 14, 2026 0

The United Arab Emirates has achieved a significant milestone in pharmaceutical innovation with the Emirates Drug Establishment (EDE) granting regulatory…

Read More
Unlocking Superior Fruit Quality: "Housekeeping" Gene Discovery Promises Enhanced Nutrition and Flavor Without Sacrificing Plant GrowthBiogen Pauses or Terminates Investment in Most of Apellis’ Legacy Research Programs Following $5.6 Billion AcquisitionThe Dawn of In Vivo Cell Therapies: A New Era in Precision Medicine Unfolds Amidst Significant Investment and InnovationThe Great Debate over AI Cognitive Models: How Zhejiang University Challenged the Centaur Study and the Future of Machine Psychology
The Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactEliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic ProportionsMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric Growth
2026 PharmSci 360 adds tracks on research credibility and post-animal drug development7 Advanced Python Design Patterns for Data ScientistsFrom Childhood Wonder to Smithsonian Curator: Gabriela Farfan’s Scientific Journey into the World of MineralsThe Architectural Evolution of Genius: How Ancient DNA Folding Unlocked the Intelligence of Cephalopods
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
2026 PharmSci 360 adds tracks on research credibility and post-animal drug development
Lana Keisha Oct 27, 2026
Data Science & Bioinformatics
7 Advanced Python Design Patterns for Data Scientists
Evan Lee Salim Oct 27, 2026
Environmental & Analytical Chemistry
From Childhood Wonder to Smithsonian Curator: Gabriela Farfan’s Scientific Journey into the World of Minerals
Abdurrohim Arsyad Oct 27, 2026
Molecular & Cell Biology
The Architectural Evolution of Genius: How Ancient DNA Folding Unlocked the Intelligence of Cephalopods
Angie Faith Oct 27, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ